CEDAR GROVE, N.J.--(BUSINESS WIRE)--State of the Art Medical Products, Inc. today announced that it has signed a three-year distribution agreement with SafeOp Surgical, Inc., a privately held medical device company. Under the terms of the agreement, SOTA will have the exclusive rights to distribute SafeOp’s EPAD™ portable neuromonitoring system to healthcare facilities in the New York Metropolitan area (Hudson Valley, New York City and Long Island), New Jersey, Connecticut, Delaware and Pennsylvania. The EPAD™ system enables the detection of nerve damage and residual paralysis during surgical procedures.
“For over 30 years, SOTA has been bringing to our customers cutting-edge technology products that can provide both better patient care and a financial advantage,” said Keith Lambie, president and founder of SOTA. “SafeOp’s EPAD™ system is just such a revolutionary product with its ability to deliver a new and needed level of patient safety to surgeries where such monitoring had not been cost-effective. As with all the products we represent, we’ve done our homework. We anticipate great success in selling EPAD™.”
SafeOp’s EPAD™ system was developed particularly for the rapid detection of Positioning Effect (“PE”). PE is a frequent complication of some surgeries (e.g., orthopedic, general, cardiac, or urological surgery), whereby peripheral nerves may be damaged due to unrecognized extended compression or stretching, or compromise of their blood supply. The EPAD™ system also allows easy-to-use monitoring of the neuromuscular junction to help detect residual paralysis, which may occur when paralyzing agents have not sufficiently worn off at the end of surgery. It offers real-time feedback, allowing caregivers to adjust the patient’s position in time to avoid nerve injury or to intervene when residual paralysis is present.
“This relationship is a key step in bringing to market our unique, cost-effective alternative to expensive insourced- and outsourced-driven neuromonitoring for certain spine surgeries,” said Gene Cattarina, SafeOp president and chief executive officer. “We’re delighted to have entered into this agreement with SOTA, an organization with an uncanny knack for identifying and successfully marketing new medical technologies. They are an ideal fit to distribute the EPAD™ system in one of the most concentrated hospital markets in the country.”
About State of the Art Medical Products, Inc.
State of the Art Medical Products, Inc. (SOTA) is a specialty medical sales and distribution company. SOTA's sales territory includes the New York Metropolitan area (Hudson Valley, New York City and Long Island), New Jersey, Connecticut, Delaware and Pennsylvania. SOTA’s management team has over 75 years of management, sales and clinical experience. To properly support its manufacturers and its customers, SOTA has evolved into three separate sales teams servicing three specific markets: Advanced Surgical Technologies, Cardiovascular / Interventional Radiology and Surgical. Supporting the sales team is an in-house staff located in Cedar Grove, New Jersey. Visit SOTA’swebsite at www.sotamedical.com.
About SafeOp Surgical, Inc.
SafeOp Surgical, Inc. is a Hunt Valley, Maryland-based medical device company that has developed the FDA-approved EPAD™ system. The EPAD™ system enables basic neurological monitoring in a wide array of surgical procedures where full monitoring, which requires the continuous presence of a technologist and neurologist, may not be indicated, cost-effective or feasible. SafeOp currently markets the EPAD™ system to medical centers throughout the United States. For more information, visit the SafeOp website at www.safeopsurgical.com.
